GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sernova Biotherapeutics Inc (FRA:PSH0) » Definitions » Short Percentage of Float

Sernova Biotherapeutics (FRA:PSH0) Short Percentage of Float


View and export this data going back to 2014. Start your Free Trial

What is Sernova Biotherapeutics Short Percentage of Float?

Short Percentage of Float is the percentage of shares shorted compared to the float.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.

Competitive Comparison of Sernova Biotherapeutics's Short Percentage of Float

For the Biotechnology subindustry, Sernova Biotherapeutics's Short Percentage of Float, along with its competitors' market caps and Short Percentage of Float data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sernova Biotherapeutics's Short Percentage of Float Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sernova Biotherapeutics's Short Percentage of Float distribution charts can be found below:

* The bar in red indicates where Sernova Biotherapeutics's Short Percentage of Float falls into.


;
;

Sernova Biotherapeutics Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sernova Biotherapeutics Inc (FRA:PSH0) » Definitions » Short Percentage of Float
Comparable Companies
NEOE:ONCO TSXV:MIR TSXV:COV TSXV:NRX TSXV:SHRX XCNQ:GLAB TSX:HBP TSX:ONC TSX:MBX TSX:MDNA VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
SEOVF:USA PSH0:Germany SVA:Canada
Address
700 Collip Circle, Suite 114, London, ON, CAN, N6G 4X8
Website
https://www.sernova.com
Sernova Biotherapeutics Inc is a clinical-stage company developing regenerative medicines. The company develops Cell Pouch with human donor cells or stem cells to create a biohybrid organ. The Cell Pouch is a implantable medical device designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells, which then release proteins, hormones, or other factors into the bloodstream for the long-term treatment of multiple chronic diseases such as type 1 diabetes, hypothyroid disease, and rare diseases such as hemophilia A.

Sernova Biotherapeutics Headlines

No Headlines